MyFinsight
Home
About
Contact
slncf: the income statement
Download
Download image
Net loss
-$20,958K
Income tax expense
$1K
Loss before income
tax expense
-$20,957K
Benefit from r&d credit
$2,583K
Other income, net
$770K
Foreign currency
gain/(loss), net
$1,934K
Revenue
$159K
Operating loss
-$26,244K
Gross profit
$95K
Cost of sales
$64K
General and
administrative expenses
$5,795K
Research and development
costs
$20,544K
Back
Back
Income Statement
source: myfinsight.com
Silence Therapeutics plc (SLNCF)
Silence Therapeutics plc (SLNCF)